spacer

GO Term History: Displaying 56 audit records for all terms for the date 2005-11-27

From (YYYY-MM-DD):
To (YYYY-MM-DD):
Period:
Category:
Terms:
Limit:
Date Specification

You can specify an explicit date range that you are interested in by setting the "From" and "To" parameters; this will limit the data displayed to those changes that were recorded within that (inclusive) date range.

Alternatively, you can use the "Period" parameter to view the GO term changes that occurred over a specific number of Day(s), Week(s), Month(s) or Year(s) before a specified date.

If you do not enter a "To" date, then the period will be relative to the current date. If, however, you do specify a "To" value, then the "Period" value will display records in the timeframe up to and including that specified date.

Category

You can use this field to specify what types of term changes you are interested in seeing.

Terms

You can enter a list of GO Terms in this field to limit the changes displayed. Please note that only changes made to directly listed terms will be displayed, not term descendants.

Limit

The default number of records returned is 500, however you can increase or decrease this limit. In order to prevent possible browser problems, the maximum upper limit is 10,000.

Introduction

This page displays the differences recorded in the full Gene Ontology OBO v1.2 file as audited by the UniProt-GOA database during its daily update cycle.
If there is any delay in uploading the current OBO file, the changes displayed and the date recorded for these changes may not correspond to when the changes to the OBO file were committed.

All changes

Timestamp GO ID GO Term Name Action Category Detail
2005-11-27 GO:0001719 inhibition of caspase activation Deleted TERM inhibition of caspase activation
2005-11-27 GO:0031914 negative regulation of synaptic plasticity Added TERM negative regulation of synaptic plasticity
2005-11-27 GO:0031915 positive regulation of synaptic plasticity Added TERM positive regulation of synaptic plasticity
2005-11-27 GO:0031916 regulation of synaptic metaplasticity Added TERM regulation of synaptic metaplasticity
2005-11-27 GO:0031917 negative regulation of synaptic metaplasticity Added TERM negative regulation of synaptic metaplasticity
2005-11-27 GO:0031918 positive regulation of synaptic metaplasticity Added TERM positive regulation of synaptic metaplasticity
2005-11-27 GO:0031919 vitamin B6 transport Added TERM vitamin B6 transport
2005-11-27 GO:0031920 pyridoxal transport Added TERM pyridoxal transport
2005-11-27 GO:0031921 pyridoxal phosphate transport Added TERM pyridoxal phosphate transport
2005-11-27 GO:0031922 pyridoxamine transport Added TERM pyridoxamine transport
2005-11-27 GO:0031923 pyridoxine transport Added TERM pyridoxine transport
2005-11-27 GO:0031924 vitamin B6 transporter activity Added TERM vitamin B6 transporter activity
2005-11-27 GO:0031925 pyridoxal transmembrane transporter activity Added TERM pyridoxal transporter activity
2005-11-27 GO:0031926 pyridoxal phosphate transmembrane transporter activity Added TERM pyridoxal phosphate transporter activity
2005-11-27 GO:0031927 pyridoxamine transmembrane transporter activity Added TERM pyridoxamine transporter activity
2005-11-27 GO:0031928 pyridoxine transmembrane transporter activity Added TERM pyridoxine transporter activity
2005-11-27 GO:0043534 blood vessel endothelial cell migration Added TERM endothelial cell migration
2005-11-27 GO:0043026 regulation of caspase activation Deleted TERM regulation of caspase activation
2005-11-27 GO:0043154 negative regulation of cysteine-type endopeptidase activity involved in apoptotic process Updated TERM negative regulation of caspase activity
2005-11-27 GO:0001719 inhibition of caspase activation Deleted DEFINITION Any process that results in preventing the activation of the pro-apoptotic caspases.
2005-11-27 GO:0043026 regulation of caspase activation Deleted DEFINITION Any process that modulates the frequency, rate or extent of caspase activation.
2005-11-27 GO:0043540 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex Added DEFINITION A homodimeric, bifunctional enzyme complex which catalyzes the synthesis and degradation of fructose 2,6-bisphosphate, and is required for both glycolysis and gluconeogenesis.
2005-11-27 GO:0043534 blood vessel endothelial cell migration Added DEFINITION The orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels during angiogenesis.
2005-11-27 GO:0043537 negative regulation of blood vessel endothelial cell migration Added DEFINITION Any process that stops, prevents or reduces the rate, frequency or extent of endothelial cell migration.
2005-11-27 GO:0031917 negative regulation of synaptic metaplasticity Added DEFINITION A process that decreases synaptic metaplasticity. Metaplasticity is a higher-order form of plasticity and is manifest as a change in the ability to induce subsequent synaptic plasticity that is the ability of synapses to change as circumstances require.
2005-11-27 GO:0031914 negative regulation of synaptic plasticity Added DEFINITION A process that decreases synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
2005-11-27 GO:0043536 positive regulation of blood vessel endothelial cell migration Added DEFINITION Any process that activates or increases the rate, frequency or extent of endothelial cell migration.
2005-11-27 GO:0031918 positive regulation of synaptic metaplasticity Added DEFINITION A process that increases synaptic metaplasticity. Metaplasticity is a higher-order form of plasticity and is manifest as a change in the ability to induce subsequent synaptic plasticity that is the ability of synapses to change as circumstances require.
2005-11-27 GO:0031915 positive regulation of synaptic plasticity Added DEFINITION A process that increases synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
2005-11-27 GO:0043539 protein serine/threonine kinase activator activity Added DEFINITION Increases the activity of a protein serine/threonine kinase.
2005-11-27 GO:0031921 pyridoxal phosphate transport Added DEFINITION The directed movement of pyridoxal phosphate into, out of, within or between cells; pyridoxal phosphate is pyridoxal phosphorylated at the hydroxymethyl group of C-5, and is the active form of vitamin B6.
2005-11-27 GO:0031926 pyridoxal phosphate transmembrane transporter activity Added DEFINITION Enables the directed movement of pyridoxal phosphate into, out of, within or between cells; pyridoxal phosphate is pyridoxal phosphorylated at the hydroxymethyl group of C-5, and is the active form of vitamin B6.
2005-11-27 GO:0031920 pyridoxal transport Added DEFINITION The directed movement of pyridoxal into, out of, within or between cells. Pyridoxal, 3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde, is one of the vitamin B6 compounds. Pyridoxal, pyridoxamine and pyridoxine are collectively known as vitamin B6, and are efficiently converted to the biologically active form of vitamin B6, pyridoxal phosphate.
2005-11-27 GO:0031925 pyridoxal transmembrane transporter activity Added DEFINITION Enables the directed movement of pyridoxal into, out of, within or between cells. Pyridoxal, 3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde, is one of the vitamin B6 compounds. Pyridoxal, pyridoxamine and pyridoxine are collectively known as vitamin B6, and are efficiently converted to the biologically active form of vitamin B6, pyridoxal phosphate.
2005-11-27 GO:0031922 pyridoxamine transport Added DEFINITION The directed movement of pyridoxamine into, out of, within or between cells. Pyridoxamine, 4-(aminomethyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol, is one of the vitamin B6 compounds. Pyridoxal, pyridoxamine and pyridoxine are collectively known as vitamin B6, and are efficiently converted to the biologically active form of vitamin B6, pyridoxal phosphate.
2005-11-27 GO:0031927 pyridoxamine transmembrane transporter activity Added DEFINITION Enables the directed movement of pyridoxamine into, out of, within or between cells. Pyridoxamine, 4-(aminomethyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol, is one of the vitamin B6 compounds. Pyridoxal, pyridoxamine and pyridoxine are collectively known as vitamin B6, and are efficiently converted to the biologically active form of vitamin B6, pyridoxal phosphate.
2005-11-27 GO:0031923 pyridoxine transport Added DEFINITION The directed movement of pyridoxine into, out of, within or between cells. Pyridoxine, 2-methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine, is one of the vitamin B6 compounds. Pyridoxal, pyridoxamine and pyridoxine are collectively known as vitamin B6, and are efficiently converted to the biologically active form of vitamin B6, pyridoxal phosphate.
2005-11-27 GO:0031928 pyridoxine transmembrane transporter activity Added DEFINITION Enables the directed movement of pyridoxine into, out of, within or between cells. Pyridoxine, 2-methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine, is one of the vitamin B6 compounds. Pyridoxal, pyridoxamine and pyridoxine are collectively known as vitamin B6, and are efficiently converted to the biologically active form of vitamin B6, pyridoxal phosphate.
2005-11-27 GO:0043538 regulation of actin phosphorylation Added DEFINITION Any process that modulates the frequency, rate or extent of the transfer of one or more phosphate groups to an actin molecule.
2005-11-27 GO:0043535 regulation of blood vessel endothelial cell migration Added DEFINITION Any process that modulates the frequency, rate or extent of endothelial cell migration.
2005-11-27 GO:0031916 regulation of synaptic metaplasticity Added DEFINITION A process that modulates synaptic metaplasticity. Metaplasticity is a higher-order form of plasticity and is manifest as a change in the ability to induce subsequent synaptic plasticity that is the ability of synapses to change as circumstances require.
2005-11-27 GO:0031919 vitamin B6 transport Added DEFINITION The directed movement of any of the vitamin B6 compounds -- pyridoxal, pyridoxamine and pyridoxine and the active form, pyridoxal phosphate -- into, out of, within or between cells.
2005-11-27 GO:0031924 vitamin B6 transporter activity Added DEFINITION Enables the directed movement of any of the vitamin B6 compounds -- pyridoxal, pyridoxamine and pyridoxine and the active form, pyridoxal phosphate -- into, out of, within or between cells.
2005-11-27 GO:0043535 regulation of blood vessel endothelial cell migration Added TERM regulation of endothelial cell migration
2005-11-27 GO:0043536 positive regulation of blood vessel endothelial cell migration Added TERM positive regulation of endothelial cell migration
2005-11-27 GO:0043537 negative regulation of blood vessel endothelial cell migration Added TERM negative regulation of endothelial cell migration
2005-11-27 GO:0043538 regulation of actin phosphorylation Added TERM regulation of actin phosphorylation
2005-11-27 GO:0043539 protein serine/threonine kinase activator activity Added TERM protein serine/threonine kinase activator activity
2005-11-27 GO:0043540 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex Added TERM 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 complex
2005-11-27 GO:0001719 inhibition of caspase activation Deleted SYNONYM negative regulation of caspase activation
2005-11-27 GO:0043154 negative regulation of cysteine-type endopeptidase activity involved in apoptotic process Added SYNONYM inhibition of caspase activation
2005-11-27 GO:0043154 negative regulation of cysteine-type endopeptidase activity involved in apoptotic process Added SYNONYM negative regulation of caspase activation
2005-11-27 GO:0043281 regulation of cysteine-type endopeptidase activity involved in apoptotic process Added SYNONYM regulation of caspase activation
2005-11-27 GO:0043539 protein serine/threonine kinase activator activity Added SYNONYM protein ser/thr kinase activator activity
2005-11-27 GO:0043154 negative regulation of cysteine-type endopeptidase activity involved in apoptotic process Added SECONDARY GO:0001719 (inhibition of caspase activation)
2005-11-27 GO:0043281 regulation of cysteine-type endopeptidase activity involved in apoptotic process Added SECONDARY GO:0043026 (regulation of caspase activation)

Terms

Timestamp GO ID GO Term Name Action Category Detail
2005-11-27 GO:0001719 inhibition of caspase activation Deleted TERM inhibition of caspase activation
2005-11-27 GO:0031914 negative regulation of synaptic plasticity Added TERM negative regulation of synaptic plasticity
2005-11-27 GO:0031915 positive regulation of synaptic plasticity Added TERM positive regulation of synaptic plasticity
2005-11-27 GO:0031916 regulation of synaptic metaplasticity Added TERM regulation of synaptic metaplasticity
2005-11-27 GO:0031917 negative regulation of synaptic metaplasticity Added TERM negative regulation of synaptic metaplasticity
2005-11-27 GO:0031918 positive regulation of synaptic metaplasticity Added TERM positive regulation of synaptic metaplasticity
2005-11-27 GO:0031919 vitamin B6 transport Added TERM vitamin B6 transport
2005-11-27 GO:0031920 pyridoxal transport Added TERM pyridoxal transport
2005-11-27 GO:0031921 pyridoxal phosphate transport Added TERM pyridoxal phosphate transport
2005-11-27 GO:0031922 pyridoxamine transport Added TERM pyridoxamine transport
2005-11-27 GO:0031923 pyridoxine transport Added TERM pyridoxine transport
2005-11-27 GO:0031924 vitamin B6 transporter activity Added TERM vitamin B6 transporter activity
2005-11-27 GO:0031925 pyridoxal transmembrane transporter activity Added TERM pyridoxal transporter activity
2005-11-27 GO:0031926 pyridoxal phosphate transmembrane transporter activity Added TERM pyridoxal phosphate transporter activity
2005-11-27 GO:0031927 pyridoxamine transmembrane transporter activity Added TERM pyridoxamine transporter activity
2005-11-27 GO:0031928 pyridoxine transmembrane transporter activity Added TERM pyridoxine transporter activity
2005-11-27 GO:0043534 blood vessel endothelial cell migration Added TERM endothelial cell migration
2005-11-27 GO:0043026 regulation of caspase activation Deleted TERM regulation of caspase activation
2005-11-27 GO:0043154 negative regulation of cysteine-type endopeptidase activity involved in apoptotic process Updated TERM negative regulation of caspase activity
2005-11-27 GO:0043535 regulation of blood vessel endothelial cell migration Added TERM regulation of endothelial cell migration
2005-11-27 GO:0043536 positive regulation of blood vessel endothelial cell migration Added TERM positive regulation of endothelial cell migration
2005-11-27 GO:0043537 negative regulation of blood vessel endothelial cell migration Added TERM negative regulation of endothelial cell migration
2005-11-27 GO:0043538 regulation of actin phosphorylation Added TERM regulation of actin phosphorylation
2005-11-27 GO:0043539 protein serine/threonine kinase activator activity Added TERM protein serine/threonine kinase activator activity
2005-11-27 GO:0043540 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex Added TERM 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 complex

Definition/synonyms

Timestamp GO ID GO Term Name Action Category Detail
2005-11-27 GO:0001719 inhibition of caspase activation Deleted DEFINITION Any process that results in preventing the activation of the pro-apoptotic caspases.
2005-11-27 GO:0043026 regulation of caspase activation Deleted DEFINITION Any process that modulates the frequency, rate or extent of caspase activation.
2005-11-27 GO:0043540 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex Added DEFINITION A homodimeric, bifunctional enzyme complex which catalyzes the synthesis and degradation of fructose 2,6-bisphosphate, and is required for both glycolysis and gluconeogenesis.
2005-11-27 GO:0043534 blood vessel endothelial cell migration Added DEFINITION The orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels during angiogenesis.
2005-11-27 GO:0043537 negative regulation of blood vessel endothelial cell migration Added DEFINITION Any process that stops, prevents or reduces the rate, frequency or extent of endothelial cell migration.
2005-11-27 GO:0031917 negative regulation of synaptic metaplasticity Added DEFINITION A process that decreases synaptic metaplasticity. Metaplasticity is a higher-order form of plasticity and is manifest as a change in the ability to induce subsequent synaptic plasticity that is the ability of synapses to change as circumstances require.
2005-11-27 GO:0031914 negative regulation of synaptic plasticity Added DEFINITION A process that decreases synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
2005-11-27 GO:0043536 positive regulation of blood vessel endothelial cell migration Added DEFINITION Any process that activates or increases the rate, frequency or extent of endothelial cell migration.
2005-11-27 GO:0031918 positive regulation of synaptic metaplasticity Added DEFINITION A process that increases synaptic metaplasticity. Metaplasticity is a higher-order form of plasticity and is manifest as a change in the ability to induce subsequent synaptic plasticity that is the ability of synapses to change as circumstances require.
2005-11-27 GO:0031915 positive regulation of synaptic plasticity Added DEFINITION A process that increases synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
2005-11-27 GO:0043539 protein serine/threonine kinase activator activity Added DEFINITION Increases the activity of a protein serine/threonine kinase.
2005-11-27 GO:0031921 pyridoxal phosphate transport Added DEFINITION The directed movement of pyridoxal phosphate into, out of, within or between cells; pyridoxal phosphate is pyridoxal phosphorylated at the hydroxymethyl group of C-5, and is the active form of vitamin B6.
2005-11-27 GO:0031926 pyridoxal phosphate transmembrane transporter activity Added DEFINITION Enables the directed movement of pyridoxal phosphate into, out of, within or between cells; pyridoxal phosphate is pyridoxal phosphorylated at the hydroxymethyl group of C-5, and is the active form of vitamin B6.
2005-11-27 GO:0031920 pyridoxal transport Added DEFINITION The directed movement of pyridoxal into, out of, within or between cells. Pyridoxal, 3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde, is one of the vitamin B6 compounds. Pyridoxal, pyridoxamine and pyridoxine are collectively known as vitamin B6, and are efficiently converted to the biologically active form of vitamin B6, pyridoxal phosphate.
2005-11-27 GO:0031925 pyridoxal transmembrane transporter activity Added DEFINITION Enables the directed movement of pyridoxal into, out of, within or between cells. Pyridoxal, 3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde, is one of the vitamin B6 compounds. Pyridoxal, pyridoxamine and pyridoxine are collectively known as vitamin B6, and are efficiently converted to the biologically active form of vitamin B6, pyridoxal phosphate.
2005-11-27 GO:0031922 pyridoxamine transport Added DEFINITION The directed movement of pyridoxamine into, out of, within or between cells. Pyridoxamine, 4-(aminomethyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol, is one of the vitamin B6 compounds. Pyridoxal, pyridoxamine and pyridoxine are collectively known as vitamin B6, and are efficiently converted to the biologically active form of vitamin B6, pyridoxal phosphate.
2005-11-27 GO:0031927 pyridoxamine transmembrane transporter activity Added DEFINITION Enables the directed movement of pyridoxamine into, out of, within or between cells. Pyridoxamine, 4-(aminomethyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol, is one of the vitamin B6 compounds. Pyridoxal, pyridoxamine and pyridoxine are collectively known as vitamin B6, and are efficiently converted to the biologically active form of vitamin B6, pyridoxal phosphate.
2005-11-27 GO:0031923 pyridoxine transport Added DEFINITION The directed movement of pyridoxine into, out of, within or between cells. Pyridoxine, 2-methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine, is one of the vitamin B6 compounds. Pyridoxal, pyridoxamine and pyridoxine are collectively known as vitamin B6, and are efficiently converted to the biologically active form of vitamin B6, pyridoxal phosphate.
2005-11-27 GO:0031928 pyridoxine transmembrane transporter activity Added DEFINITION Enables the directed movement of pyridoxine into, out of, within or between cells. Pyridoxine, 2-methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine, is one of the vitamin B6 compounds. Pyridoxal, pyridoxamine and pyridoxine are collectively known as vitamin B6, and are efficiently converted to the biologically active form of vitamin B6, pyridoxal phosphate.
2005-11-27 GO:0043538 regulation of actin phosphorylation Added DEFINITION Any process that modulates the frequency, rate or extent of the transfer of one or more phosphate groups to an actin molecule.
2005-11-27 GO:0043535 regulation of blood vessel endothelial cell migration Added DEFINITION Any process that modulates the frequency, rate or extent of endothelial cell migration.
2005-11-27 GO:0031916 regulation of synaptic metaplasticity Added DEFINITION A process that modulates synaptic metaplasticity. Metaplasticity is a higher-order form of plasticity and is manifest as a change in the ability to induce subsequent synaptic plasticity that is the ability of synapses to change as circumstances require.
2005-11-27 GO:0031919 vitamin B6 transport Added DEFINITION The directed movement of any of the vitamin B6 compounds -- pyridoxal, pyridoxamine and pyridoxine and the active form, pyridoxal phosphate -- into, out of, within or between cells.
2005-11-27 GO:0031924 vitamin B6 transporter activity Added DEFINITION Enables the directed movement of any of the vitamin B6 compounds -- pyridoxal, pyridoxamine and pyridoxine and the active form, pyridoxal phosphate -- into, out of, within or between cells.
2005-11-27 GO:0001719 inhibition of caspase activation Deleted SYNONYM negative regulation of caspase activation
2005-11-27 GO:0043154 negative regulation of cysteine-type endopeptidase activity involved in apoptotic process Added SYNONYM inhibition of caspase activation
2005-11-27 GO:0043154 negative regulation of cysteine-type endopeptidase activity involved in apoptotic process Added SYNONYM negative regulation of caspase activation
2005-11-27 GO:0043281 regulation of cysteine-type endopeptidase activity involved in apoptotic process Added SYNONYM regulation of caspase activation
2005-11-27 GO:0043539 protein serine/threonine kinase activator activity Added SYNONYM protein ser/thr kinase activator activity

Other

Timestamp GO ID GO Term Name Action Category Detail
2005-11-27 GO:0043154 negative regulation of cysteine-type endopeptidase activity involved in apoptotic process Added SECONDARY GO:0001719 (inhibition of caspase activation)
2005-11-27 GO:0043281 regulation of cysteine-type endopeptidase activity involved in apoptotic process Added SECONDARY GO:0043026 (regulation of caspase activation)
spacer
Please send comments, suggestions or bug reports to goa@ebi.ac.uk. Click here for details of how to cite UniProt-GOA and QuickGO.
183ms